Oral Bacteria on Suture Materials - Clinical Comparison of an Antibacterial-coated and a Non-coated Suture Material

Bacterial Colonization Clinical Trial

Official title:

Oral Bacteria on Suture Materials - Clinical Comparison of an Antibacterial-coated and a Non-coated Suture Material (VICRYL PLUS® vs. VICRYL®, Ethicon) in Intraoral Dentoalveolar Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00946049
• Other study ID #: 323/05
• Status: Completed
• Phase: N/A
• First received: July 22, 2009
• Last updated: July 23, 2009
• Start date: March 2005
• Est. completion date: February 2008

Study information

• Verified date: July 2009
• Source: University Hospital Freiburg
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

Antibacterial Triclosan-coated suture material (VICRYL PLUS®, Ethicon) and non-coated (VICRYL®) was compared for bacterial colonization after third molar extraction. Sutures were removed postoperatively and adhered bacteria were investigated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: February 2008
• Est. primary completion date: June 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• planned surgical extraction of 1 to 4 wisdom teeth

• no inflammation and pain within the planned surgical area

• legal age

• clinically healthy patient

Exclusion Criteria:

• allergy to Triclosan or phenols

• gravidity/lactation

• immunosuppression due to drugs or diseases

• severe general diseases

• long-term medication

• intake or use of other antibiotical drugs/devices

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

• Bacterial Colonization

Intervention

Device:
• Vicryl Plus

• Vicryl

Locations

Country	Name	City	State
Germany	Albert-Ludwigs-University Freiburg, Department for Oral and Maxillofacial Surgery	Freiburg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Freiburg

Country where clinical trial is conducted

Germany,